Vera Therapeutics, Inc. (VERA) — Dilution Risk Analysis

Current Snapshot

Vera Therapeutics, Inc. (VERA) has a DilutionWatch score of 19/10 and is classified as LOW risk. The score date in the source data is 2026-10-03T03:45:52.527348.

This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.

Share Structure

Shares Outstanding
72,063,335 Source
Public Float
52,055,526 Source
Float as % of Outstanding
72.2%

Dilution Risk Score

Score: 19/10 Source (as of 2026-10-03T03:45:52.527348)

Recent SEC Filings

Recent filing forms in the source payload: 4 8, 3 1, 8-K 1.

FormFiledAccession
4 2026-03-16 0001861684-26-000005
3 2026-03-09 0001814238-26-000004
4 2026-03-09 0001814238-26-000005
8-K 2026-03-09 0001193125-26-098783
4 2026-02-25 0002108080-26-000004
4 2026-02-25 0001819688-26-000005
4 2026-02-25 0001859453-26-000004
4 2026-02-25 0001872792-26-000004
4 2026-02-25 0002006910-26-000004
4 2026-02-06 0002006910-26-000002

Dilution Risk Drivers

DriverStored ValueSource
Cash runway 27 months Source
Three-year share count growth 62.18% Source

DilutionWatch Analysis

Risk Level
LOW (Score: 19/10) Source
Cash Runway
27 months Source
Share Count Growth (3-Year)
62.18% Source

What This Page Does Not Estimate

DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.

Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.